These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22174993)

  • 1. Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis.
    Layegh P; Rajabi O; Jafari MR; Emamgholi Tabar Malekshah P; Moghiman T; Ashraf H; Salari R
    J Parasitol Res; 2011; 2011():656523. PubMed ID: 22174993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
    Rajabi O; Layegh P; Hashemzadeh S; Khoddami M
    Dermatol Ther; 2016 Sep; 29(5):358-363. PubMed ID: 27073044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by
    Eskandari SE; Khamesipour A; Jaafari MR; Javadi A; Mohammadi AM; Valian HK; Nassiri-Kashani M; Goyonlo VM; Firooz A
    Iran J Microbiol; 2021 Oct; 13(5):718-723. PubMed ID: 34900170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.
    Khamesipour A; Mohammadi A; Jaafari M; Eskandari S; Tasbihi M; Javadi A; Afshari F; Mortazavi H; Firooz A
    East Mediterr Health J; 2022 Sep; 28(9):658-663. PubMed ID: 36205204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Moradi S; Derakhshan R; Haftbaradaran E
    BMC Complement Altern Med; 2007 Apr; 7():13. PubMed ID: 17466071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of intralesional Glucantime plus niosomal zinc sulphate in comparison with intralesional Glucantime plus cryotherapy in the treatment of acute cutaneous leishmaniasis, a randomized clinical trial.
    Farajzadeh S; Ahmadi R; Mohammadi S; Pardakhty A; Khalili M; Aflatoonian M
    J Parasit Dis; 2018 Dec; 42(4):616-620. PubMed ID: 30538362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative assessment of interventions for treating cutaneous leishmaniasis: A network meta-analysis of randomized clinical trials.
    Sridharan K; Sivaramakrishnan G
    Acta Trop; 2021 Aug; 220():105944. PubMed ID: 33957088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis.
    Maleki M; Karimi G; Tafaghodi M; Raftari S; Nahidi Y
    Indian J Dermatol; 2012 Mar; 57(2):118-22. PubMed ID: 22615508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A
    Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.
    Spinicci M; Zammarchi L; Gramiccia M; Di Muccio T; Bartolozzi D; Corsi P; Trotta M; Bartoloni A
    J Travel Med; 2021 Aug; 28(6):. PubMed ID: 32918547
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major.
    Jaffary F; Nilforoushzadeh MA; Tavakoli N; Zolfaghari B; Shahbazi F
    Adv Biomed Res; 2014; 3():111. PubMed ID: 24804185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
    Faghihi G; Tavakoli-kia R
    Clin Exp Dermatol; 2003 Jan; 28(1):13-6. PubMed ID: 12558620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between intralesional injection of zinc sulfate 2 % solution and intralesional meglumine antimoniate in the treatment of acute old world dry type cutaneous leishmaniasis: a randomized double-blind clinical trial.
    Farajzadeh S; Hakimi Parizi M; Haghdoost AA; Mohebbi A; Mohammadi S; Pardakhty A; Eybpoosh S; Heshmatkhah A; Vares B; Saryazdi S; Fekri AR; Mohebbi E
    J Parasit Dis; 2016 Sep; 40(3):935-9. PubMed ID: 27605813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
    Moosavian SA; Fallah M; Jaafari MR
    Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
    Yesilova Y; Surucu HA; Ardic N; Aksoy M; Yesilova A; Oghumu S; Satoskar AR
    J Dermatolog Treat; 2016; 27(1):83-7. PubMed ID: 26105204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice.
    Kalat SA; Khamesipour A; Bavarsad N; Fallah M; Khashayarmanesh Z; Feizi E; Neghabi K; Abbasi A; Jaafari MR
    Exp Parasitol; 2014 Aug; 143():5-10. PubMed ID: 24780938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
    Sadeghian G; Nilfroushzadeh MA; Iraji F
    Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis.
    Córdoba S; Gandolfo Cano M; Aguado M; Huerta-Brogera M; Romero A; Martínez-Morán C; Borbujo J
    Allergy; 2012 Dec; 67(12):1609-11. PubMed ID: 23067046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The topical treatment of anthroponotic cutaneous leishmaniasis with the tincture of thioxolone plus benzoxonium chloride (Thio-Ben) along with cryotherapy: a single-blind randomized clinical trial.
    Daie Parizi MH; Karvar M; Sharifi I; Bahrampour A; Heshmat Khah A; Rahnama Z; Baziar Z; Amiri R
    Dermatol Ther; 2015; 28(3):140-6. PubMed ID: 25847678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I; Farajzadeh S; Rahnama Z; Fathabadi EA; Heshmatkhah A
    Int J Dermatol; 2012 Oct; 51(10):1221-5. PubMed ID: 22994669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.